CD70 mutations were distributed at a comparable frequency in both the GCB and non‐GCB DLBCL subtypes (24.1% vs. 18.4%), and no significant difference in mutation frequency was observed between samples obtained at diagnosis and relapse (21.1% vs. 16.2%) (Figure S1A,B). The gene discussed is CD70; the disease is diffuse large B-cell lymphoma.